BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/18/2022 7:25:42 AM | Browse: 565 | Download: 1365
 |
Received |
|
2022-03-01 02:23 |
|
Peer-Review Started |
|
2022-03-01 02:24 |
|
First Decision by Editorial Office Director |
|
2022-04-18 06:16 |
|
Return for Revision |
|
2022-04-18 06:16 |
|
Revised |
|
2022-04-19 09:46 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2022-07-15 03:27 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2022-07-19 15:49 |
|
Articles in Press |
|
2022-07-19 15:49 |
|
Edit the Manuscript by Language Editor |
|
2022-07-12 16:40 |
|
Typeset the Manuscript |
|
2022-07-22 06:24 |
|
Publish the Manuscript Online |
|
2022-08-18 07:25 |
| ISSN |
2220-3206 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Behavioral Sciences |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Underlying disease may increase mortality risk in users of atypical antipsychotics
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Zhi-Peng Li, Yu-Shun You, Jun-Dong Wang and Lian-Ping He |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Curriculum Reform Project of Taizhou University in 2021 |
xkg2021087 |
|
| Corresponding Author |
Lian-Ping He, PhD, Teacher, School of Medicine, Taizhou University, No. 1139 Shifu Avenue, Jiaojiang District, Taizhou 318000, Zhejiang Province, China. lianpinghe@tzc.edu.cn |
| Key Words |
Aripiprazole; Atypical antipsychotics; Dementia; Mortality rate; Psychiatry |
| Core Tip |
Schizophrenia is a group of the most common types of mental illness. Type I schizophrenia involves mainly positive symptoms and type II schizophrenia involves mainly negative symptoms. The patients are indifferent and lack initiative. Clinically, atypical antipsychotics are often used as first-line drugs for first-episode schizophrenia. Although antipsychotics may increase mortality to some extent, observational studies suggest that atypical antipsychotics are associated with a lower risk of all-cause mortality when compared with conventional antipsychotics. |
| Publish Date |
2022-08-18 07:25 |
| Citation |
Li ZP, You YS, Wang JD, He LP. Underlying disease may increase mortality risk in users of atypical antipsychotics. World J Psychiatry 2022; 12(8): 1112-1114 |
| URL |
https://www.wjgnet.com/2220-3206/full/v12/i8/1112.htm |
| DOI |
https://dx.doi.org/10.5498/wjp.v12.i8.1112 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
